UNSPSC 51373339: Meperidine/promethazine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS.

UNSPSC 51373339 Meperidine/promethazine is a Commodity code that captures pharmaceutical products state and local governments procure for emergency response, public health, and community health support. Recent solicitations show state and local buyers acquiring naloxone and related drug-deactivation systems for community health initiatives and emergency preparedness — work that extends beyond the code's nominal pharmaceutical ingredient focus to include harm-reduction and substance-abuse response equipment and supplies. The purchasing pattern reflects public-health agencies and county health departments acquiring these products as part of broader opioid response and overdose-prevention programs.

Seminole County, Florida represents the available recent activity under this code, having posted an IFB (Invitation for Bids) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with a response deadline of July 26, 2023. The solicitation specifies electronic bid submission through the county's e-Procurement Portal, E-Verify compliance, drug-free workplace certification, and a two-year initial term with one-year renewal option. Geographic activity under this code is limited in the available data to Florida; without additional recent opportunities from other states or jurisdictions, the scope of state and local procurement momentum across the code cannot be characterized beyond this single solicitation.